Disease relevance of HYPE

• Prophylactic antibiotic use in severe acute pancreatitis: hemlock, help, or hype [1]?
• Sorting the hype from the facts in melanoma [2].
• Methotrexate in the treatment of primary biliary cirrhosis: the hype and the hope [3].
• Gene therapy for lung disease: hype or hope [4]?
• Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype [5]?

Psychiatry related information on HYPE

• Laser pointers: the facts, media hype, and hysteria [6].
• 'Reprogenetics': hype, phobia and choice: an unreserved advocate of new reproductive technologies argues his case [7].

High impact information on HYPE

• Hope or hype for lexipafant [8]?
• Ventricular remodeling: hype or hope [9]?
• Complementary and alternative medicine in neurology: hype, hope and hazards [10].
• Hype about glucosamine [11].
• Looking beyond the hype that has accompanied much of the commentary in the area, the future of pharmacogenetics will depend on how competing interests and options are resolved [12].

Chemical compound and disease context of HYPE

• Glucosamine for osteoarthritis: magic, hype, or confusion? It's probably safe-but there's no good evidence that it works [13].
• Lenalidomide for myelodysplastic syndromes: finally, hope not hype [14].

Biological context of HYPE

• There has been a great deal of "hype" about the potential of the human genome mapping project [15].
• Biotechnology and the popular press: hype and the selling of science [16].
• Functional proteomics: separating the substance from the hype [17].
• Science communication in transition: genomics hype, public engagement, education and commercialization pressures [18].
• Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers [19].

Anatomical context of HYPE

• Stem cells: hype or hope [20]?
• Bone tissue engineering: hope vs hype [21].
• Therapeutic angiogenesis in patients with advanced coronary artery disease: hype or hope [22]?
• Selective depletion of macrophages in atherosclerotic plaques: myth, hype, or reality [23]?
• Pulmonary vein ablation in atrial fibrillation: hype or hope [24]?

Associations of HYPE with chemical compounds

• BACKGROUND: The present study was conducted to examine the possibility of modulating interferon (IFN-gamma)-induced immunogenicity by a novel compound that is composed of a PLA2 inhibitor linked to hyaluronic acid (HYPE) [25].
• Ramipril use in Canada: HOPE or HYPE [26]?
• Insulin action was assessed prevailing fasting glucose levels before and after hype insulinemia (2-h insulin infusion at 2.0 mU / kg / min) [27].
• Melatonin and immune function: hype or hypothesis [28]?
• Ascorbic acid: hype, hoax, or healer [29]?

Regulatory relationships of HYPE

• RESULTS: In FACS, a profound inhibition in MHC class I and ICAM-1 staining was observed in stimulated or unstimulated cells that were incubated with HYPE [25].

Analytical, diagnostic and therapeutic context of HYPE

• Less hype, more biology needed for gene therapy [30].
• Cell transplant therapy for stroke: hope or hype [31].
• Reduced-intensity conditioning allogeneic stem cell transplantation: hype, reality or time for a rethink [32]?
• Living donor liver transplantation: is the hype over [33]?
• Primary chemotherapy for breast cancer: hope or hype [34]?

References